相关实验视频
Updated: Apr 30, 2026

08:32
Extraction of Tissue Antigens for Functional Assays
Published on: September 10, 2012
11.3K
在中优化GAD65114-122对潜在的1型糖尿病抗原特异性免疫治疗的自身抗原
Lei Fu1,2,3,4,5, Kevin Chun Chan1,2,3, Qinglu Zhong2,3,5
1Institute of Urology, The Third Affiliated Hospital of Shenzhen University, Luohu Hospital Group, Shenzhen 518000, China.
The journal of physical chemistry. B
|December 9, 2025
概括
研究人员通过增强人类白细胞抗原 (HLA) 结合,为1型糖尿病 (T1D) 疫苗设计了改进的GAD65仿原体. 关键位置的特定突变显著提高了结合亲和力,确定了T1D免疫疗法开发的有希望的候选人.
科学领域:
- 免疫学 免疫学 免疫学
- 计算生物学 计算生物学
- 疫苗开发 疫苗开发
背景情况:
- 1型糖尿病 (T1D) 涉及针对胰腺β细胞抗原的T细胞.
- 特定于小岛自身抗原的CD8+ T细胞是T1D病变发生的核心.
- 在HLA-A*02:01个体中对GAD65 (谷氨酸脱酶65) 的反应性集中在VMNILLQYV表位上.
研究的目的:
- 为1型糖尿病 (T1D) 疫苗开发设计具有增强人类白细胞抗原 (HLA) 结合力的GAD65仿原体.
- 为了确定特定的突变,提高GAD65仿原体与HLA-A*02:01.01的结合亲和力.
- 评估这些增强型仿原体作为T1D疫苗候选者的潜力.
主要方法:
- 使用了全原子分子动力学 (MD) 模拟.
- 员工自由能量扰动 (FEP) 的计算.
- 对HLA-A*02:01-GAD65(114-122) 结合亲缘关系进行评估的单,双和交换突变.
主要成果:
- 确定了GAD65表位的位置3和7对于增强HLA结合至关重要.
- 发现3位的负电荷残留物 (酸,谷氨酸) 和7位的疏水性残留物 (氨酸,异氨酸) 改善了结合.
- 观察到附加或协同效应,在3位和7位发生双重突变,N3D_Q7M,N3D_Q7I,N3E_Q7M和N3E_Q7I显示强大的结合.
结论:
- 设计了具有显著增强HLA-A*02:01结合的优化GAD65仿原体.
- 在位置3和7的特定突变是改善基于抗原的疫苗设计的关键.
- 已识别的双重突变是T1DT细胞激活研究中实验验证的有希望的候选者.
更多相关视频
相关概念视频
Type I Diabetes I: Introduction
45
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
Type I Diabetes II: Pathophysiology
75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28

